Hematology
Daniel Deangelo, M.D.,PH.D.
Chief, Division of Leukemia Institute Physician; Professor of Medicine, Harvard Medical School
Daniel J. DeAngelo, MD, PhD, is Chief of the Division of Leukemia at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School, specializing in hematology-oncology with a focus on adult leukemias and related disorders. He primarily treats patients with acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic leukemias, myelodysplastic syndromes (MDS), myeloproliferative disorders, systemic mastocytosis, and idiopathic hypereosinophilic syndrome (IHES). His
30+
Years in Practice
Credentials
Board Certifications
- Internal Medicine
- Hematology
- Medical Oncology
Education & Training
- Albert Einstein College of Medicine — M.D., Ph.D. (1993)
- Massachusetts General Hospital — Residency, Internal Medicine
- Brigham and Women's Hospital/Dana-Farber Cancer Institute — Fellowship, Hematology and Oncology
Peer Recognition
2016-2017, 2019-2025 (9 years)
- Castle Connolly — Top Doctor
2012-2026 (15 years)
Recognition & Leadership
Leadership Roles
- Chief, Division of Leukemia Institute Physician
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
Languages
English
Experience
30+ years in practice